Health360/InGene

# Record card
285
Thematic areas
ICT & Electronics / Sensor/multi-sensor technology, instrumentation
Health & Biotech / Medical imaging & equipment
Health & Biotech / Bio-informatics
ICT & Electronics / Information processing, information system, workflow management
Health & Biotech / Diagnostic, Medical imaging & advanced bioimaging
Description

Health360 is a software framework for building cloud platforms to monitor the health of subjects recruited in clinical trials, residents of social housing or athletes in sports teams. The framework is based on interconnected and configurable modules to implement platforms that meet specific needs while maintaining a high level of usability.

The ultimate goal is the implementation of innovative approaches to personalised medicine (4P) and the use of advanced artificial intelligence technologies for health data analysis. The system integrates solutions to enable compliance with the General Data Protection Regulation (GDPR).

Ingene, a platform developed with Health360, focuses on the management of neuromuscular diseases. It provides tools and functionalities for functional assessment, objective neurological examination, subcutaneous fat estimation from MRI images, genetic data processing and more.

Type of innovation
Product / process innovation in integration with an already existing technology
Description of innovative features / Competitive advantages

Health360 provides the ability to generate quality datasets that are essential for Artificial Intelligence applications to study disease progression, prevent pathological conditions, conduct clinical trials or simply proactively monitor the health status of subjects under observation. This is possible thanks to the functionalities offered by the platforms built with Health360, which allow the collection and generation of quality data, their integration and the processing of entire datasets in multicentre studies, while maintaining the necessary confidentiality of the data, combined with extreme ease of use.

InGene stands out as a unique technology in the context of rare diseases such as neuromuscular diseases, thanks to the possibility of integrating and analysing clinical, instrumental and genetic data and represents a valid research support and diagnostic aid.

Reference market
Incremental innovation
Development stage
Prototype
TRL
7
8
Advantages
Product/process/service/technology optimization
Patentable technology
No
Patented technology
No
Publication of technology
Published
Technology validation/demonstration
External validation
Market positioning
Italian
European
International
Partner required
Enteprise
Public research center/university
Private research center
Seed capital
Cooperation in national /european / international project

Information
For more information and/or to be put in contact with the Research Team, please contact the Project Manager:

Barbara Angelini - Project Manager
CNR - Unità Valorizzazione della Ricerca
Phone number 06.49932415
E-mail barbara.angelini@cnr.it